Aggressive breast cancer malignancies metastasize to bone and are associated with dysregulation of the RANK/RANKL/OPG pathway and can increase the RANKL/OPG ratio, which would favor excessive osteolysis [33]. The gene discussed is TNFSF11; the disease is breast cancer.